Genomic targets of the human c-Myc protein

Genes and Development

Volumn 17, Issue 9, 2003, Pages 1115-1129

  Fernandez, Paula C ^a,c   Frank, Scott R ^a   Wang, Luquan ^a   Schroeder, Marianne ^a   Liu, Suxing ^a   Greene, Jonathan ^a   Cocito, Andrea ^b   Amati, Bruno ^a,b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Chromatin; Genome; Human; Myc; Transcription factor

Indexed keywords

GENOMIC DNA; MESSENGER RNA; MYC PROTEIN;

ACETYLATION; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOINFORMATICS; CHROMATIN; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA SEQUENCE; E BOX ELEMENT; GENE FREQUENCY; GENE INDUCTION; GENE LOCATION; GENE LOCUS; GENE OVEREXPRESSION; GENE TARGETING; GENETIC CONSERVATION; GENETIC SCREENING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION;

CELL LINE; CHROMATIN; CPG ISLANDS; DNA; E-BOX ELEMENTS; GENE EXPRESSION REGULATION; GENOME, HUMAN; HISTONES; HUMANS; PRECIPITIN TESTS; PROTO-ONCOGENE PROTEINS C-MYC; SEQUENCE ANALYSIS, DNA;

OTHER SEQUENCES;

EID: 0038185378     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1067003     Document Type: Article

References (54)

1. Amati, B., Dalton, S., Brooks, M.W., Littlewood, T.D., Evan, G.I., and Land, H. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359: 423-426.
2. Amati, B., Alevizopoulos, K., and Vlach, J. 1998. Myc and the cell cycle. Front Biosci. 3: D250-D268.
3. Bates, C.M., Kharzai, S., Erwin, T., Rossant, J., and Parada, L.F. 2000. Role of N-myc in the developing mouse kidney. Dev. Biol. 222: 317-325.
4. Bird, A. 1987. CpG islands as gene markers in the vertebrate nucleus. TIGS 3: 342-347.
5. Blackwood, E.M. and Eisenman, R.N. 1991. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211-1217.
6. Bouchard, C., Dittrich, O., Kiermaier, A., Dohmann, K., Menkel, A., Eilers, M., and Lüscher, B. 2001. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes & Dev. 15: 2042-2047.
7. Boyd, K.E. and Farnham, P.J. 1997. Myc versus USF: Discrimination at the cad gene is determined by core promoter elements. Mol. Cell. Biol. 17: 2529-2537.
8. Brandvold, K.A., Neiman, P., and Ruddell, A. 2000. Angiogenesis is an early event in the generation of myc-induced lymphomas. Oncogene 19: 2780-2785.
9. de Alboran, I.M., O'Hagan, R.C., Gartner, F., Malynn, B., Davidson, L., Rickert, R., Rajewsky, K., DePinho, R.A., and Alt, F.W. 2001. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14: 45-55.
10. Di Croce, L., Raker, V.A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo Coco, F., Kouzarides, T., Nervi, C., et al. 2002. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295: 1079-1082.
11. Douglas, N.C., Jacobs, H., Bothwell, A.L., and Hayday, A.C. 2001. Defining the specific physiological requirements for c-Myc in T cell development. Nat. Immunol. 2:307-315.
12. Eischen, C.M., Roussel, M.F., Korsmeyer, S.J., and Cleveland, J.L. 2001. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol. Cell. Biol. 21: 7653-7662.
13. Frank, S.R., Schroeder, M., Fernandez, P., Taubert, S., and Amati, B. 2001. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes & Dev. 15: 2069-2082.
14. Gardiner-Garden, M. and Frommer, M. 1987. CpG islands in vertebrate genomes. J. Mol. Biol. 196: 261-282.
15. Garte, S. 1993. The c-myc oncogene in tumor progression. Crit. Rev. Oncogenesis 4: 435-449.
16. Grandori, C., Cowley, S.M., James, L.P., and Eisenman, R.N. 2000. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16: 653-699.
17. Greasley, P.J., Bonnard, C., and Amati, B. 2000. Myc induces the nucleolin and BN51 genes: Possible implications in ribosome biogenesis. Nucleic Acids Res. 28: 446-453.
18. Henriksson, M. and Lüscher, B. 1996. Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv. Cancer Res. 68: 109-182.
19. Hogenesch, J.B., Ching, K.A., Batalov, S., Su, A.I., Walker, J.R., Zhou, Y., Kay, S.A., Schultz, P.G., and Cooke, M.P. 2002. A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genes. Cell 106: 413-415.
20. Iyer, V.R., Horak, C.E., Scafe, C.S., Botstein, D., Snyder, M., and Brown, P.O. 2001. Genomic binding sites of the yeast cellcycle transcription factors SBF and MBF. Nature 409: 533-538.
21. Johnston, L.A., Prober, D.A., Edgar, B.A., Eisenman, R.N., and Gallant, P. 1999. Drosophila myc regulates cellular growth during development. Cell 98: 779-790.
22. Jones, P.A. and Baylin, S.B. 2002. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3: 415-428.
23. Kretzner, L., Blackwood, E.M., and Eisenman, R.N. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature 359: 426-429.
24. Lieb, J.D., Liu, X., Botstein, D., and Brown, P.O. 2001. Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association. Nat. Genet. 28: 327-334.
25. Mateyak, M.K., Obaya, A.J., Adachi, S., and Sedivy, J.M. 1997. Phenotypes of c-myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8: 1039-1048.
26. Menssen, A. and Hermeking, H. 2002. Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes. Proc. Natl. Acad. Sci. 99: 6274-6279.
27. Morrish, F., Giedt, C., and Hockenbery, D. 2003. c-MYC apoptotic function is mediated by NRF-1 target genes. Genes & Dev. 17: 240-255.
28. Ngo, C.V., Gee, M., Akhtar, N., Yu, D., Volpert, O., Auerbach, R., and Thomas-Tikhonenko, A. 2000. An in vivo function for the transforming Myc protein: Elicitation of the angiogenic phenotype. Cell Growth Differ. 11: 201-210.
29. Nikiforov, M.A., Chandriani, S., Park, J., Kotenko, I., Matheos, D., Johnsson, A., McMahon, S.B., and Cole, M.D. 2002. TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins. Mol. Cell. Biol. 22: 5054-5063.
30. O'Connell, B.C., Cheung, A.F., Simkevich, C.P., Tam, W., Ren, X., Mateyak, M.K., and Sedivy, J.M. 2003. A large scale genetic analysis of c-Myc-regulated gene expression patterns. J. Biol. Chem. (In press).
31. O'Hagan, R.C., Schreiber-Agus, N., Chen, K., David, G., Engelman, J.A., Schwab, R., Alland, L., Thomson, C., Ronning, D.R., Sacchettini, J.C., et al. 2000. Gene-target recognition among members of the myc superfamily and implications for oncogenesis. Nat. Genet. 24: 113-119.
32. Orian, A., van Steensel, B., Delrow, J., Bussemaker, H.J., Li, L., Sawado, T., Williams, E., Loo, L.W.M., Cowley, S.M., Yost, C., et al. 2003. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes & Dev. (this issue).
33. Oster, S.K., Ho, C.S., Soucie, E.L., and Penn, L.Z. 2002. The myc oncogene: Marvelous1Y Complex. Adv. Cancer Res. 84: 81-154.
34. Pelengaris, S., Littlewood, T., Khan, M., Elia, G., and Evan, G. 1999. Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell 3: 565-577.
35. Pelengaris, S., Khan, M., and Evan, G.I. 2002. Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109: 321-334.
36. Prendergast, G.C., Lawe, D., and Ziff, E.B. 1991. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65: 395-407.
37. Ren, B., Robert, F., Wyrick, J.J., Aparicio, O., Jennings, E.G., Simon, I., Zeitlinger, J., Schreiber, J., Hannett, N., Kanin, E., et al. 2000. Genome-wide location and function of DNA binding proteins. Science 290: 2306-2309.
38. 2/M checkpoints. Genes & Dev. 16: 245-256.
39. Richards, E.J. and Elgin, S.C. 2002. Epigenetic codes for heterochromatin formation and silencing: Rounding up the usual suspects. Cell 108: 489-500.
40. Schuhmacher, M., Kohlhuber, F., Holzel, M., Kaiser, C., Burtscher, H., Jarsch, M., Bornkamm, G.W., Laux, G., Polack, A., Weidle, U.H., et al. 2001. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res. 29: 397-406.
41. Schuldiner, O. and Benvenisty, N. 2001. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Oncogene 20: 4984-4994.
42. Simon, I., Barnett, J., Hannett, N., Harbison, C.T., Rinaldi, N.J., Volkert, T.L., Wyrick, J.J., Zeitlinger, J., Gifford, D.K., Jaakkola, T.S., et al. 2001. Serial regulation of transcriptional regulators in the yeast cell cycle. Cell 106: 697-708.
43. Solomon, D.L.C., Amati, B., and Land, H. 1993. Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. Nucleic Acids Res. 21: 5372-5376.
44. Teitz, T., Wei, T., Valentine, M.B., Vanin, E.F., Grenet, J., Valentine, V.A., Behm, F.G., Look, A.T., Lahti, J.M., and Kidd, V.J. 2000. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med. 6: 529-535.
45. Trumpp, A., Refaeli, Y., Oskarsson, T., Gasser, S., Murphy, M., Martin, G.R., and Bishop, J.M. 2001. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414: 768-773.
46. Vettese-Dadey, M., Grant, P.A., Hebbes, T.R., Crane-Robinson, C., Allis, C.D., and Workman, J.L. 1996. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J. 15: 2508-2518.
47. Wang, L., Wu, Q., Qiu, P., Mirza, A., McGuirk, M., Kirschmeier, P., Greene, J.R., Wang, Y., Pickett, C.B., and Liu, S. 2001. Analyses of P53 target genes in the human genome by bio-informatic and microarray approaches. J. Biol. Chem. 276: 43604-43610.
48. Waters, C.M., Littlewood, T.D., Hancock, D.C., Moore, J.P., and Evan, G.I. 1991. c-myc protein expression in untransformed fibroblasts. Oncogene 6: 797-805.
49. Watson, J.D., Oster, S.K., Shago, M., Khosravi, F., and Penn, L.Z. 2002. Identifying genes regulated in a Myc-dependent manner. J. Biol. Chem. 277: 36921-36930.
50. Weinmann, A.S., Yan, P.S., Oberley, M.J., Huang, T.H., and Farnham, P.J. 2002. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes & Dev. 16: 235-244.
51. Winkles, J.A. 1998. Serum- and polypeptide growth factor-inducible gene expression in mouse fibroblasts. Prog. Nucleic Acid Res. Mol. Biol. 58: 41-78.
52. Xu, D., Popov, N., Hou, M., Wang, Q., Bjorkholm, M., Gruber, A., Menkel, A.R., and Henriksson, M. 2001. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc. Natl. Acad. Sci. 98: 3826-3831.
53. Xu, Y. and Uberbacher, E.C. 1997. Automated gene identification in large-scale genomic sequences. J. Comput. Biol. 4: 325-338.
54. Zeller, K.I., Haggerty, T.J., Barrett, J.F., Guo, Q., Wonsey, D.R., and Dang, C.V. 2001. Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J. Biol. Chem. 276: 48285-48291.